A pioneer in AI nanomaterial innovation, unleashing potential. BUY

研报英文原文证据摘录

A pioneer in AI nanomaterial innovation, unleashing potential. BUY

6 July 2026

Pharmaceuticals / Biotechnology

Metis

Overview of nanotechnology-based drug

Definition of nanotechnology

Nanotechnology involves the design, characterization, and application of materials

and systems with at least one dimension between 1 and 100 nanometers. At this

nanoscale, unique physical, chemical, and biological properties emerge, such as

enhanced surface area, reactivity, and distinctive optical, electronic, and

mechanical characteristics. These properties have driven transformative

innovations across life sciences, including drug delivery, diagnostics, human

medicine, and animal health.

Development pathway of nanotechnology in drug development

The application of nanotechnology in drug development has evolved significantly,

progressing from enhancing existing drug dosage forms to enabling advanced

therapies and addressing previously un-druggable targets. Initially, nanomaterials

like microspheres and nano-micelles improved drug solubility and release. This was

followed by advancements such as LNPs and GalNAc-conjugated systems, which

propelled nucleic acid-based therapies (mRNA, siRNA). The field is now focused on

developing novel delivery systems for precise targeting and controlled release of

innovative drug modalities, with future prospects to address challenging targets

and inaccessible organs across all disease areas.

Key benefits of nanotechnological application

Nanotechnology in drug development offers compelling advantages over

conventional approaches, significantly improving drug efficacy, safety, and

targeting capabilities. It enables sustained drug release, which enhances patient

adherence and reduces dosing frequency. Furthermore, it facilitates precise,